A carregar...

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt vs Deferred Laser Treatment: 3-year Randomized Trial Results

OBJECTIVE: To report 3-year follow-up within a previously reported randomized trial evaluating prompt versus deferred (for ≥24 weeks) focal/grid laser treatment in eyes treated with intravitreal 0.5-mg ranibizumab for diabetic macular edema (DME). DESIGN: Multicenter randomized clinical trial. PARTI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3490003/
https://ncbi.nlm.nih.gov/pubmed/22999634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2012.08.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!